182 related articles for article (PubMed ID: 11046087)
1. Analgesic synergy between topical lidocaine and topical opioids.
Kolesnikov YA; Chereshnev I; Pasternak GW
J Pharmacol Exp Ther; 2000 Nov; 295(2):546-51. PubMed ID: 11046087
[TBL] [Abstract][Full Text] [Related]
2. Analgesic synergy between topical opioids and topical non-steroidal anti-inflammatory drugs in the mouse model of thermal pain.
Kolesnikov Y; Sõritsa D
Eur J Pharmacol; 2008 Jan; 579(1-3):126-33. PubMed ID: 18001710
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the tail formalin test in mice as a new model to assess local analgesic effects.
Kolesnikov Y; Cristea M; Oksman G; Torosjan A; Wilson R
Brain Res; 2004 Dec; 1029(2):217-23. PubMed ID: 15542077
[TBL] [Abstract][Full Text] [Related]
4. Analgesic synergy between topical morphine and butamben in mice.
Kolesnikov YA; Cristea M; Pasternak GW
Anesth Analg; 2003 Oct; 97(4):1103-1107. PubMed ID: 14500165
[TBL] [Abstract][Full Text] [Related]
5. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
Kolesnikov Y; Pasternak GW
J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration.
Cichewicz DL; McCarthy EA
J Pharmacol Exp Ther; 2003 Mar; 304(3):1010-5. PubMed ID: 12604676
[TBL] [Abstract][Full Text] [Related]
7. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
8. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
Hernández-Delgadillo GP; Cruz SL
Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
11. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids.
Barrett AC; Cook CD; Terner JM; Craft RM; Picker MJ
Psychopharmacology (Berl); 2001 Nov; 158(2):154-64. PubMed ID: 11702089
[TBL] [Abstract][Full Text] [Related]
12. Interaction of intrathecally infused morphine and lidocaine in rats (part I): synergistic antinociceptive effects.
Saito Y; Kaneko M; Kirihara Y; Sakura S; Kosaka Y
Anesthesiology; 1998 Dec; 89(6):1455-63. PubMed ID: 9856720
[TBL] [Abstract][Full Text] [Related]
13. Isobolographic analysis of caramiphen and lidocaine on spinal anesthesia in rats.
Chen YW; Chu CC; Chen YC; Wang JJ; Hung CH
Neurosci Lett; 2010 Jan; 469(1):174-8. PubMed ID: 19962431
[TBL] [Abstract][Full Text] [Related]
14. Analgesic synergism between intrathecal morphine and cyclooxygenase-2 inhibitors in mice.
Pinardi G; Prieto JC; Miranda HF
Pharmacol Biochem Behav; 2005 Sep; 82(1):120-4. PubMed ID: 16102800
[TBL] [Abstract][Full Text] [Related]
15. Local anesthetics potentiate spinal morphine antinociception.
Akerman B; Arweström E; Post C
Anesth Analg; 1988 Oct; 67(10):943-8. PubMed ID: 3421498
[TBL] [Abstract][Full Text] [Related]
16. Spinal synergy between nonselective cyclooxygenase inhibitors and morphine antinociception in mice.
Miranda HF; Prieto JC; Pinardi G
Brain Res; 2005 Jul; 1049(2):165-70. PubMed ID: 15936732
[TBL] [Abstract][Full Text] [Related]
17. Topical methadone and meperidine analgesic synergy in the mouse.
Kolesnikov YA; Oksman G; Pasternak GW
Eur J Pharmacol; 2010 Jul; 638(1-3):61-4. PubMed ID: 20433826
[TBL] [Abstract][Full Text] [Related]
18. Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception.
Fischer BD; Dykstra LA
J Pharmacol Exp Ther; 2006 Sep; 318(3):1300-6. PubMed ID: 16772537
[TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive effects of localized administration of opioids compared with lidocaine.
Hassan HG; Pilcher CW; Akerman B; Renck H
Reg Anesth; 1989; 14(3):138-44. PubMed ID: 2577247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
